|
|
|
|
 |
|  =Subscribers Only |
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
Auto Beat
Bangalore Tigers
Blogspotting
Brand New Day
Byte of the Apple
Economics Unbound
Eye on Asia
Fine On Media
Green Biz
Hot Property
Investing Insights
Management IQ
NEXT: Innovation
NussbaumOnDesign
Tech Beat
Working Parents
TECHNOLOGY
J.D. Power Ratings
Product Reviews
Tech Stats
Wildstrom: Tech Maven
AUTOS
Home Page
Auto Reviews
Classic Cars
Car Care & Safety
Hybrids
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip INVESTING Investing: Europe Annual Reports BW 50 S&P Picks & Pans Stock Screeners Free S&P Stock Report SCOREBOARDS Hot Growth 100 Mutual Funds Info Tech 100 S&P 500 B-SCHOOLS Undergrad Programs MBA Blogs MBA Profiles MBA Rankings Who's Hiring Grads |
|
 JULY 9, 2004 Ebookers: Hot Ticket for the Long Haul? Europe's No. 2 online travel outfit has promised the world and failed to deliver, but admirers still see a stock that can go the distance JULY 6, 2004 Can Avastin Cure Genentech's Slide? After bidding up the stock, investors have backed off while awaiting more evidence that the cancer treatment will be a hit JUNE 30, 2004 A Tech Shelter from Rate Hikes? When S&P looked at how the sector fared during past Fed tightenings, it found that fleeing them may be the wrong move JUNE 29, 2004 The Scoop on CNET Even as the Web's tech-news leader rides the rebound in online ads, it's looking more like a traditional, fixed-cost media outfit JUNE 22, 2004 For the Palms, a Firmer Grip? While hardware outfit PalmOne's sales and stock price soared, bad news drove PalmSource down. Still, many pros remain upbeat JUNE 21, 2004 Research in Motion's Bumper Harvest The maker of the BlackBerry handheld is enjoying robust growth, and its stock has soared. Some analysts think this is just the beginning JUNE 17, 2004 No Red Flag at Red Hat? The Linux powerhouse's business prospects could be strong enough to overcome the latest top-exec's departure, though questions remain JUNE 11, 2004 Little Cheer for SCO Shareholders Considering the legal swamp the software maker is stuck in, its dismal quarterly earnings report is hardly uplifting JUNE 8, 2004 Blue Nile's Real Sparkle The online jeweler's numbers catch the eye, especially for what they say about how it stacks up against bricks-and-mortar gem chains JUNE 8, 2004 Waiting for Net2Phone to Pick Up Wall Street appears impatient with the Net telephony pioneer's progress, and that could be an opening for long-term investors JUNE 3, 2004 Intel: Why the Street Sees a Good Bet Thanks to the rebound in tech spending and new products, the chipmaker stands to cash in on the investments it made during the downturn JUNE 2, 2004 SCO Boosts Its War Chest A settlement with a major shareholder frees up cash for the legal battle with IBM. As for the stock, expect no easy victories MAY 24, 2004 HP and Dell: One Game, Two Winners As they vie for market dominance, not to mention bragging rights, one thing is clear: Both will score as IT spending recovers MAY 19, 2004 Heading South at Nortel It's a never-ending drip, says one analyst. Indeed, the giant telecom-gear maker's woes will likely worsen before they improve MAY 17, 2004 Can Nextel Strike Up the Bandwidth? The wireless spectrum it needs may carry a high price -- and what it gets might not be what it wants. Dismal prospects? Maybe not APRIL 22, 2004 Wyeth's Quickening Pulse Though fen-phen lawsuits chill some investors, bargain-hunters like the drugmaker's earnings, manufacturing fixes, and solid pipeline APRIL 16, 2004 Can Symantec Keep Cooking? Its long-term prospects are sound, but even a slight mishap could be overly disappointing to investors used to its hot growth APRIL 15, 2004 Microsoft, the Value Stock? As the software giant matures, growth investors are finding less to like, while players who seek rebound plays are coming onboard APRIL 14, 2004 Amgen's Rocky Adolescence The No. 1 biotech is struggling to show investors it can keep up its youthful growth rates even as it matures into a real drug company  View Previous Page | View Next Page | Street Wise Archive | |
|
Copyright Bloomberg L.P.